BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 722500)

  • 1. GLC determination of tilidine, nortilidine, and bisnortilidine in biological fluids with a nitrogen-sensitive detector.
    Hengy H; Vollmer KO; Gladigau V
    J Pharm Sci; 1978 Dec; 67(12):1765-8. PubMed ID: 722500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gas-chromatographic determination of nanogram amounts of enantiomers of nortilidine, a main metabolite of tilidine, in biological specimens.
    Hengy H; Vollmer KO; Gladigau V
    Clin Chem; 1978 Apr; 24(4):692-7. PubMed ID: 639277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a GLC-NPD method with a GLC-MS-SIM procedure for the determination of tilidine and its metabolites in plasma.
    Cordonnier J; Wauters A; Heyndrickx A
    J Anal Toxicol; 1987; 11(4):144-8. PubMed ID: 3626526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of tilidine in a fatal poisoning in man.
    Cordonnier J; Van den Heede M; Heyndrickx A; Wennig R
    J Anal Toxicol; 1987; 11(3):105-9. PubMed ID: 3599916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine.
    Hajda JP; Jähnchen E; Oie S; Trenk D
    J Clin Pharmacol; 2002 Nov; 42(11):1257-61. PubMed ID: 12412825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid quantification of tilidine, nortilidine, and bisnortilidine in urine by automated online SPE-LC-MS/MS.
    Köhler C; Grobosch T; Binscheck T
    Anal Bioanal Chem; 2011 Apr; 400(1):17-23. PubMed ID: 21140136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tilidine in terminal renal failure.
    Seiler KU; Jähnchen E; Trenk D; Brennscheidt U; Heintz B
    J Clin Pharmacol; 2001 Jan; 41(1):79-84. PubMed ID: 11144998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of tilidine in pharmaceutical dosage forms.
    Zivanov-Stakić D; Solomun LJ; Zivanović LJ
    Farmaco; 1989; 44(7-8):759-62. PubMed ID: 2590373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tilidine and metabolites in man.
    Vollmer KO; Thomann P; Hengy H
    Arzneimittelforschung; 1989 Oct; 39(10):1283-8. PubMed ID: 2610722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability investigation of a new tilidine/naloxone liquid formulation compared to a reference formulation.
    Martin W; Ring J; Gaupp M; Arnold P; Sennewald R; Doser K
    Arzneimittelforschung; 1999 Jul; 49(7):599-607. PubMed ID: 10442208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.
    Brennscheidt U; Brunnmüller U; Proppe D; Thomann P; Seiler KU
    Arzneimittelforschung; 2007; 57(2):106-11. PubMed ID: 17396621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidine.
    Eichbaum C; Mathes K; Burhenne J; Markert C; Blank A; Mikus G
    Basic Clin Pharmacol Toxicol; 2015 Feb; 116(2):129-33. PubMed ID: 25223231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLC determination of floxuridine in plasma using a thermionic nitrogen detector.
    De Leenheer AP; Gelijkens CF
    J Pharm Sci; 1978 Mar; 67(3):417-9. PubMed ID: 147936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cyproheptadine in plasma and urine by GLC with a nitrogen-sensitive detector.
    Hucker HB; Hutt JE
    J Pharm Sci; 1983 Sep; 72(9):1069-70. PubMed ID: 6631695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLC method for the quantification of metabolites of thymoxamine in human plasma.
    Hengy H; Von Hodenberg A; Vollmer KO
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):203-8. PubMed ID: 2935399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites.
    Musshoff F; Trafkowski J; Kuepper U; Madea B
    J Mass Spectrom; 2006 May; 41(5):633-40. PubMed ID: 16541404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trace determination of chlorpheniramine in plasma by GLC using a nitrogen-phosphorous (N-P) detector.
    Smith HT; Jacob JT; Achari RG
    J Chromatogr Sci; 1978 Nov; 16(11):561-4. PubMed ID: 730818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A GLC-nitrogen phosphorous detector assay for trifluoperazine in plasma.
    Roscoe RM; Cooper JK; Hawes EM; Midha KK
    J Pharm Sci; 1982 Jun; 71(6):625-7. PubMed ID: 7097522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism].
    Wolfert C; Merbach M; Stammler G; Emrich O; Meid AD; Burhenne J; Blank A; Mikus G
    Schmerz; 2017 Oct; 31(5):516-523. PubMed ID: 28597312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A death case involving tilidine.
    Van Boven M; Daenens P; Bruneel N
    Arch Toxicol; 1976 Oct; 36(2):121-5. PubMed ID: 1036886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.